Product Information
ARISTADA ER 1,064 MG/3.9 ML SYR is a brand product labeled by Alkermes, Inc., priced at $995.0249 per ML under NDC 65757040403. Its NADAC has been published 427 times since Jun 20, 2018.
FDA first approved this application on Oct 5, 2015.
Strength
1064 mg/3.9mL
Manufacturer
Alkermes, Inc.NDC
65757040403
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
ARIPIPRAZOLE LAUROXILApproval Type
New Drug (NDA)
FDA Application
NDA207533FDA Approved
10/5/2015
On Market Since
6/5/2017
Pharmacological Classes
Price Statistics
The NADAC for ARISTADA ER 1,064 MG/3.9 ML SYR has been published 427 times since Jun 20, 2018, and over the history we have for it it has risen 44.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $995.0249 per ML |
|---|---|
| All-time high | $995.0249 (Aug 19, 2026) |
| All-time low | $690.6004 (Jun 20, 2018) |
| 52-week high | $995.0249 |
| 52-week low | $932.1287 |
| Median price | $860.0202 |
| Average price | $854.8775 |
| Largest weekly change | +6.0% (Jan 14, 2026) |
| Weeks tracked | 427 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the aripiprazole lauroxil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ARISTADA ER 1,064 MG/3.9 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for ARISTADA ER 1,064 MG/3.9 ML SYR, manufactured by Alkermes, Inc., is $995.0249 per ML (NDC 65757040403), effective Aug 19, 2026.
How has the price of ARISTADA ER 1,064 MG/3.9 ML SYR changed over time?
Over the history we have for it, the NADAC for ARISTADA ER 1,064 MG/3.9 ML SYR has risen 44.1%. It has been tracked across 427 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for ARISTADA ER 1,064 MG/3.9 ML SYR?
Since Jun 20, 2018, the NADAC for ARISTADA ER 1,064 MG/3.9 ML SYR has ranged from a low of $690.6004 (Jun 20, 2018) to a high of $995.0249 (Aug 19, 2026), with a median of $860.0202 per ML.
Are there cheaper alternatives to ARISTADA ER 1,064 MG/3.9 ML SYR?
No other NADAC-published product currently shares the active ingredient and strength of ARISTADA ER 1,064 MG/3.9 ML SYR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ARISTADA ER 1,064 MG/3.9 ML SYR?
ARISTADA ER 1,064 MG/3.9 ML SYR (NDC 65757040403) is labeled by Alkermes, Inc., and CMS classifies it as a brand product.